Institutional investors purchased a net $2.1 million shares of BMY during the quarter ended March 2016 and now own 75.02% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 16.4 Million shares of Bristol-Myers Squibb
FIDELITY MANAGEMENT & RESEARCH C... Bought 7.8 Million shares of Bristol-Myers Squibb
THE VANGUARD GROUP, INC. Bought 5.0 Million shares of Bristol-Myers Squibb